Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Zinzani

Showing results (1-10 of 207) with videos related to

Pageof 21
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2003
Ifosfamide, epirubicin and etoposide (IEV) in non-Hodgkin's lymphoma and Hodgkin's disease: the Italian experienceP L Zinzani
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|November 15, 2012
Advanced/aggressive CTCL: improving the efficacy of treatmentP L Zinzani
Haematologica|December 24, 1997
Idarubicin in low-grade non-Hodgkin's lymphomasP L Zinzani
Haematologica|February 22, 2000
Indolent lymphomasS Tura, P L Zinzani
Haematologica|May 1, 1994
New target of chronic lymphocytic leukemia treatmentS Tura, P L Zinzani
European Journal of Haematology|October 1, 1995
FMP regimen (fludarabine, mitoxantrone, prednisone) as therapy in recurrent low-grade non-Hodgkin's lymphomaP L Zinzani, M Bendandi, S Tura
Haematologica|May 1, 1996
Purine analogs (fludarabine and 2-chlorodeoxyadenosine) as apoptosis-inducing drugs in CML therapyG Martinelli, P L Zinzani, P Farabegoli
Haematologica|November 1, 1988
Beta interferon in the treatment of mycosis fungoidesP L Zinzani, P Mazza, F Gherlinzoni
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2004
Challenging paradigms in lymphoma treatmentM Bendandi, S A Pileri, P L Zinzani
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1995
2-Chlorodeoxyadenosine in psoriasis treatmentP L Zinzani, P Ricci, M Bendandi, et al.
Pageof 21

Showing results (1-10 of 207) with videos related to

Sort By:
Pageof 21
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2003
Ifosfamide, epirubicin and etoposide (IEV) in non-Hodgkin's lymphoma and Hodgkin's disease: the Italian experienceP L Zinzani
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|November 15, 2012
Advanced/aggressive CTCL: improving the efficacy of treatmentP L Zinzani
Haematologica|December 24, 1997
Idarubicin in low-grade non-Hodgkin's lymphomasP L Zinzani
Haematologica|February 22, 2000
Indolent lymphomasS Tura, P L Zinzani
Haematologica|May 1, 1994
New target of chronic lymphocytic leukemia treatmentS Tura, P L Zinzani
European Journal of Haematology|October 1, 1995
FMP regimen (fludarabine, mitoxantrone, prednisone) as therapy in recurrent low-grade non-Hodgkin's lymphomaP L Zinzani, M Bendandi, S Tura
Haematologica|May 1, 1996
Purine analogs (fludarabine and 2-chlorodeoxyadenosine) as apoptosis-inducing drugs in CML therapyG Martinelli, P L Zinzani, P Farabegoli
Haematologica|November 1, 1988
Beta interferon in the treatment of mycosis fungoidesP L Zinzani, P Mazza, F Gherlinzoni
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2004
Challenging paradigms in lymphoma treatmentM Bendandi, S A Pileri, P L Zinzani
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1995
2-Chlorodeoxyadenosine in psoriasis treatmentP L Zinzani, P Ricci, M Bendandi, et al.
Pageof 21